2 completed, 1 withdrawn. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Withdrawn 1 |
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
Follow AMG 337: new trials by email Literature Review of AMG 337 trials Research Report on AMG 337
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer c-Met inhibitor AMG 337, placebo, oxaliplatin - Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction | Phase 1 / Phase 2 | Withdrawn | Eastern Cooperative Oncology Group | 2015-03-06 | 2023-05-25 | |
| A Phase 1/2 Study Evaluating AMG 337 in Asian Subjects AMG 337 - Stomach Neoplasms | Phase 1 / Phase 2 | Completed | Amgen | 11 | 2014-04-15 | 2021-12-28 |
| A Study of AMG 337 in Subjects With Advanced Solid Tumors AMG 337 - Advanced Malignancy, Advanced Solid Tumors | Phase 1 | Completed | Amgen | 111 | 2010-12-08 | 2022-11-07 |
Stomach Neoplasms (2) · Adenocarcinoma Of Esophagus (1) · Esophageal Neoplasms (1) · Gastrointestinal Neoplasms (1) · Neoplasms (1)
Amgen (2) · Eastern Cooperative Oncology Group (1)
United States (2) · Japan (1)
Lakshmi Rajdev (1)
U10CA180820 (1)